Advancements in Drug Repurposing: Examples in Psychiatric Medications von Okuyama, Ryo

Volltext

Strengthening the Competitiveness of Japan’s Pharmaceutical Industry: Analysis of Country Differences in the Origin of New Drugs and Japan’s Highly Productive Firm von Okuyama, Ryo

Volltext

Chronological Analysis of First-in-Class Drugs Approved from 2011 to 2022: Their Technological Trend and Origin von Okuyama, Ryo

Volltext

Trends in COVID-19 Vaccine Development: Vaccine Platform, Developer, and Nationality von Okuyama, Ryo

Volltext

mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions von Okuyama, Ryo

Volltext

Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines von Okuyama, Ryo

Volltext

Nurturing Deep Tech to Solve Social Problems: Learning from COVID-19 mRNA Vaccine Development von Okuyama, Ryo

Volltext

Modality diversification and best-in-class small-molecule drugs: Recent trend of orphan drug development von Okuyama, Ryo

Volltext

Increased contribution of small companies to late-entry drugs: a changing trend in FDA-approved drugs during the 2020s von Okuyama, Ryo

Volltext

The importance of drug target selection capability for new drug innovation: definition, fostering process, and interaction with organizational management von Okuyama, Ryo, Tsujimoto, Masaharu

Volltext

Leveraging Corporate Assets and Talent to Attract Investors in Japan: A Country with an Innovation System Centered on Large Companies von Okuyama, Ryo

Volltext

Academia’s contribution to drug discovery: current status and perspectives in Japan von OKUYAMA, Ryo

Volltext

Training system for converting current visual information to bird’s-eye view von Kaoru Sumi, Ryo Okuyama

Volltext

Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus von Lizarzaburu, Mike, Turcotte, Simon, Du, Xiaohui, Duquette, Jason, Fu, Angela, Houze, Jonathan, Li, Leping, Liu, Jinqian, Murakoshi, Michiko, Oda, Kozo, Okuyama, Ryo, Nara, Futoshi, Reagan, Jeff, Yu, Ming, Medina, Julio C.

Volltext

UDP‐N‐acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme von Okuyama, Ryo, Marshall, Stephen

Volltext

Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor γ Ligand, Cerco-A von Wakabayashi, Kenji, Hayashi, Shinko, Matsui, Yumi, Matsumoto, Takuo, Furukawa, Akihiro, Kuroha, Masanori, Tanaka, Naomi, Inaba, Tomoko, Kanda, Shoichi, Tanaka, Jun, Okuyama, Ryo, Wakimoto, Satoko, Ogata, Tsuneaki, Araki, Kazushi, Ohsumi, Jun

Volltext

Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes von Toda, Narihiro, Hao, Xiaolin, Ogawa, Yasuyuki, Oda, Kozo, Yu, Ming, Fu, Zice, Chen, Yi, Kim, Yongjae, Lizarzaburu, Mike, Lively, Sarah, Lawlis, Shauna, Murakoshi, Michiko, Nara, Futoshi, Watanabe, Nobuaki, Reagan, Jeff D, Tian, Hui, Fu, Angela, Motani, Alykhan, Liu, Qingxiang, Lin, Yi-Jyun, Zhuang, Run, Xiong, Yumei, Fan, Peter, Medina, Julio, Li, Leping, Izumi, Masanori, Okuyama, Ryo, Shibuya, Satoshi

Volltext

Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its b... von Uto, Yoshikazu, Ogata, Tsuneaki, Kiyotsuka, Yohei, Miyazawa, Yuriko, Ueno, Yuko, Kurata, Hitoshi, Deguchi, Tsuneo, Yamada, Makiko, Watanabe, Nobuaki, Takagi, Toshiyuki, Wakimoto, Satoko, Okuyama, Ryo, Konishi, Masahiro, Kurikawa, Nobuya, Kono, Keita, Osumi, Jun

Volltext

Importance of tacit knowledge in incremental innovation von Okuyama, Ryo

Volltext

Potential Regulation of Nuclear UDP-N-Acetylglucosaminyl Transferase (OGT) by Substrate Availability: Ability of Chromatin Protein to Bind UDP-N-Acetylglucosamine and Reduce OGT-Me... von Okuyama, Ryo, Marshall, Stephen

Volltext